These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 12182843

  • 1. Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
    Weiss L, Barak V, Zeira M, Abdul-Hai A, Raibstein I, Reich S, Hirschfeld E, Gross D, Slavin S.
    Cytokine; 2002 Jul 21; 19(2):85-93. PubMed ID: 12182843
    [Abstract] [Full Text] [Related]

  • 2. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
    Karussis D, Abramsky O, Rosenthal Y, Mizrachi-Koll R, Ovadia H.
    Immunol Lett; 1999 Apr 15; 67(3):203-8. PubMed ID: 10369127
    [Abstract] [Full Text] [Related]

  • 3. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
    Erälinna JP, Röyttä M, Hukkanen V, Zinhu D, Salmi AA, Salonen R.
    J Neuroimmunol; 1998 Aug 01; 88(1-2):165-76. PubMed ID: 9688338
    [Abstract] [Full Text] [Related]

  • 4. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
    Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S.
    Int Immunopharmacol; 2005 Feb 01; 5(2):231-9. PubMed ID: 15652754
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
    Lehmann D, Karussis DM, Fluresco D, Mizrachi-Koll R, Ovadia H, Shezen E, Kalland T, Abramsky O.
    J Neuroimmunol; 1997 Apr 01; 74(1-2):102-10. PubMed ID: 9119961
    [Abstract] [Full Text] [Related]

  • 6. Semliki Forest virus infection is enhanced in Th1-prone SJL mice but not in Th2-prone BALB/c mice during Linomide-induced immunomodulation.
    Peltoniemi J, Setälä N, Broberg E, Röyttä M, Hukkanen V, Salmi AA, Erälinna JP.
    J Neuroimmunol; 2002 Nov 01; 132(1-2):83-92. PubMed ID: 12417437
    [Abstract] [Full Text] [Related]

  • 7. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He JF, Yang RF, Yun LH.
    Life Sci; 2007 Oct 27; 81(19-20):1403-10. PubMed ID: 17950363
    [Abstract] [Full Text] [Related]

  • 8. Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice.
    Hartoft-Nielsen ML, Rasmussen AK, Kaas A, Bock T, Buschard K, Feldt-Rasmussen U.
    Autoimmunity; 2001 Oct 27; 33(2):79-84. PubMed ID: 11264786
    [Abstract] [Full Text] [Related]

  • 9. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S, Gross D, Weiss L.
    Transplant Proc; 1995 Dec 27; 27(6):3240. PubMed ID: 8539933
    [No Abstract] [Full Text] [Related]

  • 10. H1521, a novel derivative of 4-hydroxyquinoline-3-carboxamide, suppresses the development of lupus in mice by inducing Th1 cytokine profile in T cells.
    Xiao ZY, Chen SH, Zhou WX, Zhang YX, Cheng JP, Yang RF.
    Int Immunopharmacol; 2011 Apr 27; 11(4):435-43. PubMed ID: 21195814
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y, Nagata M, Yasuda H, Okamoto N, Arisawa K, Moriyama H, Miki M, Yokono K, Kasuga M.
    Clin Immunol Immunopathol; 1998 Feb 27; 86(2):209-18. PubMed ID: 9473384
    [Abstract] [Full Text] [Related]

  • 13. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.
    Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E, Slavin S.
    Diabetologia; 1994 Dec 27; 37(12):1195-201. PubMed ID: 7895948
    [Abstract] [Full Text] [Related]

  • 14. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A.
    J Immunol; 2001 Jan 15; 166(2):1352-9. PubMed ID: 11145720
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
    Peltoniemi J, Broberg EK, Nygårdas M, Erälinna JP, Waris M, Hukkanen V.
    Int Immunopharmacol; 2006 May 15; 6(5):817-29. PubMed ID: 16546713
    [Abstract] [Full Text] [Related]

  • 16. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression.
    Arad G, Katzenellenbogen M, Levy R, Slavin S, Kaempfer R.
    Int Immunol; 1996 Oct 15; 8(10):1603-7. PubMed ID: 8921440
    [Abstract] [Full Text] [Related]

  • 17. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
    Rapoport MJ, Weiss L, Mor A, Bistritzer T, Ramot Y, Slavin S.
    J Immunol; 1996 Nov 15; 157(10):4721-5. PubMed ID: 8906854
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).
    Slavin S, Weiss L, Xia W, Gross DJ.
    Cell Transplant; 1996 Nov 15; 5(6):627-30. PubMed ID: 8951220
    [Abstract] [Full Text] [Related]

  • 19. Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse.
    Dahlén E, Dawe K, Ohlsson L, Hall H, Hedse K, Annersten K, Aström M, Gross DJ, Hedlund G.
    Int Immunopharmacol; 2003 Jan 15; 3(1):17-30. PubMed ID: 12538031
    [Abstract] [Full Text] [Related]

  • 20. Herbal medicine Gamgungtang down-regulates autoimmunity through induction of TH2 cytokine production by lymphocytes in experimental thyroiditis model.
    Sa EH, Jin UH, Kim DS, Kang BS, Ha KT, Kim JK, Park WH, Kim CH.
    J Ethnopharmacol; 2007 Feb 12; 109(3):472-9. PubMed ID: 17049774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.